Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)
|ClinicalTrials.gov Identifier: NCT00429754|
Recruitment Status : Withdrawn (change of study population and chemotherapeutic regimen)
First Posted : February 1, 2007
Last Update Posted : January 26, 2016
Merck Sharp & Dohme Corp.
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Primary Completion Date :||No date given|
|Estimated Study Completion Date :||September 2008|